
Opinion|Videos|April 1, 2024
Paradigm Shift In Parkinson’s Disease Diagnosis
Author(s)Stuart H. Isaacson, MD, FAAN, Rajesh Pahwa, MD
The neurology experts discuss the importance of early and accurate diagnosis of Parkinson’s disease, the role of alpha-synuclein in the diagnosis of synucleinopathies and approaches to implementing screening protocols in clinical practice.
Advertisement
Episodes in this series
0:50 Diagnosis of Parkinson’s disease
3:20 Preclinical start of Parkinson’s disease
5:00 Alpha-synuclein in Parkinson’s disease
6:50 Biomarkers in Parkinson’s disease
12:00 Syn-One test for Parkinson’s disease
21:15 Advanced diagnostics in Parkinson’s disease
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Roche Unveils PrevenTRON, a Phase 3 Prevention Trial of Trontinemab in Cognitively Unimpaired Individuals at High Risk of Alzheimer Decline
2
Sanofi's Oral TREM2 Agonist SAR448851 Advances to Phase 2 TREMHANCE Trial in Early Alzheimer Disease
3
Alzheimer's Association Launches PROTECT-Cog Combination Prevention Trial
4
This Week on NeurologyLive® — July 20, 2026
5


















